4/26
03:18 pm
abt
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]
Low
Report
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]
4/26
07:20 am
abt
Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]
Low
Report
Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]
4/26
05:05 am
abt
Whey Protein Market To Reach USD 16.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]
Low
Report
Whey Protein Market To Reach USD 16.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]
4/26
02:32 am
abt
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength [Reuters]
Low
Report
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength [Reuters]
4/25
01:40 pm
abt
Europe High Pressure Non-Compliant Balloon Catheter Market Size to Worth USD 1,801.5 by 2032: Astute Analytica [Yahoo! Finance]
Low
Report
Europe High Pressure Non-Compliant Balloon Catheter Market Size to Worth USD 1,801.5 by 2032: Astute Analytica [Yahoo! Finance]
4/25
05:38 am
abt
Global Bionic Devices Industry Research, 2023-2024 & 2030: Addressing Diverse Healthcare Needs Worldwide to Sustain Growth and Fuel Develoments [Yahoo! Finance]
Low
Report
Global Bionic Devices Industry Research, 2023-2024 & 2030: Addressing Diverse Healthcare Needs Worldwide to Sustain Growth and Fuel Develoments [Yahoo! Finance]
4/24
08:07 am
abt
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO [Yahoo! Finance]
Low
Report
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO [Yahoo! Finance]
4/24
07:21 am
abt
Europe In-Vitro Diagnostics (IVD) Markets, 2023-2024 & 2029 with Abbott, bioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin Dominating [Yahoo! Finance]
Low
Report
Europe In-Vitro Diagnostics (IVD) Markets, 2023-2024 & 2029 with Abbott, bioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin Dominating [Yahoo! Finance]
4/24
04:29 am
abt
Autoimmune Collaboration and Licensing Deals Report 2024: Provides Details of 882 Autoimmune Deals Dating Back to 2016 by Company, Headline Value, Therapeutic Area and Technology Type [Yahoo! Finance]
Low
Report
Autoimmune Collaboration and Licensing Deals Report 2024: Provides Details of 882 Autoimmune Deals Dating Back to 2016 by Company, Headline Value, Therapeutic Area and Technology Type [Yahoo! Finance]
4/24
04:29 am
abt
Drug Discovery Global Market Report and Growth Forecasts 2023-2030: Collaborative Research Models, Personalized Medicine and Repurposing Existing Drugs Present Key Opportunities [Yahoo! Finance]
Low
Report
Drug Discovery Global Market Report and Growth Forecasts 2023-2030: Collaborative Research Models, Personalized Medicine and Repurposing Existing Drugs Present Key Opportunities [Yahoo! Finance]
4/24
04:06 am
abt
Rapid Influenza Diagnostic Test Market to Reach US$ 2.61 Billion by 2034: Fact.MR Report [Yahoo! Finance]
Low
Report
Rapid Influenza Diagnostic Test Market to Reach US$ 2.61 Billion by 2034: Fact.MR Report [Yahoo! Finance]
4/24
02:50 am
abt
Reckitt Sales Defy Forecast After Baby Formula Legal Row [BNN Bloomberg (Canada)]
Low
Report
Reckitt Sales Defy Forecast After Baby Formula Legal Row [BNN Bloomberg (Canada)]
4/24
01:32 am
abt
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $124.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $124.00 price target on the stock.
4/22
08:40 am
abt
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.
4/22
08:04 am
abt
Should You Pick Abbott Stock At $105 After An Upbeat Q1? [Forbes]
Low
Report
Should You Pick Abbott Stock At $105 After An Upbeat Q1? [Forbes]
4/22
01:34 am
abt
Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario [Seeking Alpha]
Low
Report
Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario [Seeking Alpha]
4/22
01:12 am
abt
D-dimer Testing Market to hit USD 2 Bn by 2032, says Global Market Insights Inc. [Yahoo! Finance]
Low
Report
D-dimer Testing Market to hit USD 2 Bn by 2032, says Global Market Insights Inc. [Yahoo! Finance]
4/20
09:14 am
abt
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation [Yahoo! Finance]
Low
Report
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation [Yahoo! Finance]
4/19
11:04 am
abt
Cardiac Marker Industry Trends, Opportunities, and Competitive Landscape 2018-2033: Features Profiles of Abbott Laboratories, Siemens, Danaher Corporation, bioMerieux, and Roche [Yahoo! Finance]
Low
Report
Cardiac Marker Industry Trends, Opportunities, and Competitive Landscape 2018-2033: Features Profiles of Abbott Laboratories, Siemens, Danaher Corporation, bioMerieux, and Roche [Yahoo! Finance]
4/19
09:54 am
abt
Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)? [Yahoo! Finance]
Low
Report
Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)? [Yahoo! Finance]
4/19
09:49 am
abt
Lyme Disease Diagnostic Market Research Report 2024: Global Trends, Forecasts and Competitive Analysis to 2030 [Yahoo! Finance]
Low
Report
Lyme Disease Diagnostic Market Research Report 2024: Global Trends, Forecasts and Competitive Analysis to 2030 [Yahoo! Finance]
4/19
07:32 am
abt
Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]
Low
Report
Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]
4/19
05:27 am
abt
Global Cancer Diagnostics Market Set to Reach US$ 280.37 Billion by 2030 with Illumina, Abbott Laboratories, Thermo Fisher Scientific, QIAGEN, Roche, Pfizer, Koninklijke Philips,& bioMérieux Leading [Yahoo! Finance]
Low
Report
Global Cancer Diagnostics Market Set to Reach US$ 280.37 Billion by 2030 with Illumina, Abbott Laboratories, Thermo Fisher Scientific, QIAGEN, Roche, Pfizer, Koninklijke Philips,& bioMérieux Leading [Yahoo! Finance]
4/19
04:57 am
abt
Global Cardiovascular Surgical Devices Market Expected to Surge to US$ 2.77 Billion by 2032 - Technological Innovations and Approvals Boosting the Market [Yahoo! Finance]
Low
Report
Global Cardiovascular Surgical Devices Market Expected to Surge to US$ 2.77 Billion by 2032 - Technological Innovations and Approvals Boosting the Market [Yahoo! Finance]
4/18
12:05 pm
abt
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.
Neutral
Report
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.